
CCRN Stock Forecast & Price Target
CCRN Analyst Ratings
Bulls say
Cross Country Healthcare is expected to see strong growth in the coming years due to recent investments in revenue-producing employees, positive market conditions, and a robust sales pipeline. However, the company is facing risks such as potential loss of significant MSP customers and the impact of telemedicine on physician staffing. Despite the recent acquisition offer from Knox Lane, the company's fundamentals suggest strong potential for growth in the long term.
Bears say
Cross Country Healthcare is a technology-enabled healthcare workforce solutions provider that saw a 2% sequential increase in revenue in Q1/26, primarily driven by its Nurse and Allied Staffing segment. However, with its pending acquisition by Knox Lane at a price of $13.25 per share, its stock price is currently trading very close to the offer price, leading us to maintain our MARKET PERFORM investment rating. We see the potential for synergies between All Star Healthcare Solutions and Cross Country's multi-segment operations, further boosting Knox Lane's ambitions in the $20+ billion U.S. healthcare staffing market. However, it is worth noting that the expected demand rebound in the industry may not be immediate, which could pose challenges for Cross Country's growth prospects in the near future.
This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.
CCRN Analyst Forecast & Price Prediction
Start investing in CCRN
Order type
Buy in
Order amount
Est. shares
0 shares